Transaction Data Systems, Inc. acquires Tabula Rasa HealthCare Group, Inc. for USD 125,000,000 (2022)

Deal facts

Buyer: Transaction Data Systems, Inc.
Target: Tabula Rasa HealthCare Group, Inc.
Deal value: USD 125,000,000
Announced: 1 August 2022
Status: Completed
Sector: Healthcare
Country: United States
Consideration: cash, earn-out

Sources

SEC_EDGAR_8K

What we know

Weekly digest

Join Exit Mode Insider

Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.

Join Exit Mode Insider, £12/mo

Deal timeline

1 update

1 Aug 2022CompletedClosed
Transaction Data Systems, Inc. completes acquisition of Tabula Rasa HealthCare Group, Inc.
Item 1.02. Termination of a Material Definitive Agreement. As previously disclosed by Tabula Rasa HealthCare, Inc., a Delaware corporation (the “ Company ”) on December 22, 2020, on December 18, 2020, the Company and certain of its then-existing subsidiaries, including Tabula Rasa Healthcare Group, Inc. (“ Seller ”), CK Solutions, LLC, Personica, LLC, TRHC TPA, LLC, and PersonifilRx, LLC, entered
Source

OpinionExit Mode editorial

The announcement that Transaction Data Systems, Inc. will acquire Tabula Rasa HealthCare Group, Inc. for $125 million highlights a persistent tension in the healthcare sector. We see this deal, closed in August 2022, as a clear signal that buyers are prioritising asset flexibility over full corporate integration. The structure is an asset sale, which allows the buyer to pick specific technologies and customer contracts while leaving behind legacy liabilities. This is a critical distinction for the SME founder watching from the sidelines, as it fundamentally alters the risk profile of the transaction compared to a standard share purchase.

The consideration mix of cash and an earn-out is equally telling. In a healthcare environment where regulatory scrutiny is intense, the earn-out component acts as a bridge between differing valuations. It aligns the seller's future performance with the buyer's integration success without requiring the buyer to commit the full $125 million upfront. For the seller, this means a portion of the final price depends on hitting specific milestones post-close. We view this not as a lack of confidence, but as a pragmatic mechanism to manage the inherent uncertainty in merging complex healthcare data systems. The asset sale structure further suggests the buyer is focused on acquiring specific capabilities rather than inheriting the entire corporate entity, which can simplify the regulatory clearance process.

The decision to structure this as an asset deal rather than a share sale also has significant implications for change-of-control covenants. In the US healthcare market, many contracts with providers or insurers contain clauses that trigger upon a change of control. By purchasing assets, the buyer can often avoid triggering these clauses, ensuring business continuity without needing to renegotiate every single agreement. This approach reduces friction and accelerates the path to revenue synergy. However, it places a heavier burden on the seller to ensure that the assets being sold are clearly defined and that the transition of staff and data is seamless to satisfy the earn-out conditions.

For the founder reading this, the immediate action is to audit your own customer contracts for change-of-control provisions before entering any serious talks. If your agreements contain strict clauses that could be triggered by a share sale, you should explicitly propose an asset sale structure in your initial term sheet to preserve deal value and reduce closing risk.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Healthcare deals More 2022 deals More asset sale deals More from Transaction Data Systems, Inc.All M&A deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

7 May 2026CompletedHealthcare

GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC to acquire Selectis Health, Inc.

GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC and Selectis Health, Inc. entered the Exit Mode archive.

Buyer: GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC
Target: Selectis Health, Inc.
Deal value: USD 15,700,000
Deal type: asset sale

Read deal Healthcare deals asset sale deals United States deals

15 April 2026CompletedHealthcare

MeiraGTx Holdings plc to acquire Janssen Pharmaceuticals, Inc.

MeiraGTx Holdings plc and Janssen Pharmaceuticals, Inc. entered the Exit Mode archive.

Buyer: MeiraGTx Holdings plc
Target: Janssen Pharmaceuticals, Inc.
Deal value: USD 25,000,000
Deal type: asset sale

Read deal Healthcare deals asset sale deals United States deals

7 April 2026Firm intentionHealthcare

Supernus Pharmaceuticals, Inc. to acquire Navitor Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. and Navitor Pharmaceuticals, Inc. entered the Exit Mode archive.

Buyer: Supernus Pharmaceuticals, Inc.
Target: Navitor Pharmaceuticals, Inc.
Deal value: USD 350,000,000
Deal type: asset sale

Read deal Healthcare deals asset sale deals United States deals

30 March 2026Firm intentionHealthcare

SCYNEXIS, Inc. to acquire Poxel SA

SCYNEXIS, Inc. and Poxel SA entered the Exit Mode archive.

Buyer: SCYNEXIS, Inc.
Target: Poxel SA
Deal value: USD 8,000,000
Deal type: asset sale

Read deal Healthcare deals asset sale deals France deals

25 March 2026CompletedHealthcare

Vireo Health of Rocky Mountain, LLC to acquire Medicine Man Technologies, Inc. d/b/a Schwazze

Vireo Health of Rocky Mountain, LLC and Medicine Man Technologies, Inc. d/b/a Schwazze entered the Exit Mode archive.

Buyer: Vireo Health of Rocky Mountain, LLC
Target: Medicine Man Technologies, Inc. d/b/a Schwazze
Deal value: USD 111,000,000
Deal type: asset sale

Read deal Healthcare deals asset sale deals United States deals

Buyer history